Heart Defect Closure Device Market Trends 2025-2034: Insights into Growth and Strategic Opportunities Ahead
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How Will the Heart Defect Closure Device Market’s Growth Rate Evolve Over the Forecast Period to 2034?
In the past few years, there has been a rapid expansion in the heart defect closure device market. This industry is expected to experience a rise from $1.11 billion in 2024 to $1.27 billion in 2025, achieving a compound annual growth rate (CAGR) of 14.5%. The outstanding growth in the previous period can be linked to the increased incidence of congenital heart conditions, an aging demographic, a higher level of health consciousness, acceleration in research and development, and progress in catheterization procedures.
The market for heart defect closure devices is projected to experience swift expansion in the coming years, reaching a value of $2.17 billion by 2029 with a compound annual growth rate (CAGR) of 14.2%. The expected growth during the forecast period can be linked to a rise in congenital defects, enhanced diagnostic methods, increased use of MRI procedures, more frequent application of 3D imaging in heart defect closure operations, and a higher incidence of ischemic stroke. Notable trends during this period involve technological progress, the creation of novel products, the production of next-generation heart closure devices, a rising detection of PFO closure devices, and the necessity to evaluate the advantages of PFO closure for the elderly population.
What Major Innovations Are Driving the Accelerated Growth of the Heart Defect Closure Device Market?
The rising prevalence of congenital heart disorders is anticipated to fuel the expansion of the heart defect closure device market in the future. Congenital heart disorders are structural abnormalities present in the heart from birth. These disorders are caused by a variety of factors including genetic predispositions, environmental factors, and issues with maternal health such as obesity, diabetes, and exposure to certain medications or infections during pregnancy. Heart defect closure devices provide a minimally invasive approach to rectify these disorders by sealing any abnormal heart openings, thereby normalizing blood flow, mitigating complications, and enhancing cardiac function. For example, an article published in the National Library of Medicine (NLM) in October 2024, based on US biomedical informatics and computational health data science research, showed a significant increase in congenital heart disorder incidents, which were at 5.46% in 2023 compared to 1.12% in 2020, 2.36% in 2021, and 3.87% in 2022. Consequently, the surging population suffering from congenital heart disorders is propelling the growth of the heart defect closure device market.
Request Your Free Heart Defect Closure Device Market Report Sample Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=16074&type=smp
Who Are the Influential Players Reshaping the Heart Defect Closure Device Market Landscape?
Major companies operating in the heart defect closure device market are:
• Abbott Laboratories_x000D_
• Medtronic_x000D_
• Koninklijke Philips N.V._x000D_
• Boston Scientific Corporation_x000D_
• Terumo Corporation_x000D_
What New and Evolving Trends Are Having a Lasting Impact on the Heart Defect Closure Device Market?
Prominent entities in the heart defect closure device market are innovating self-expanding, double-disc occluders for minimally invasive closing of heart defects. These occluders not only elevate the safety of the procedure but also enhance patient results by cutting down recovery periods, and lowering the potential for issues linked with conventional open-heart operations. For example, in September 2022, Abbott Laboratories, a health care and medical devices firm based in the US, introduced the Amplatzer Talisman PFO Occlusion System in Europe. The system is a medical apparatus designed to seal a patent foramen ovale (PFO), a irregular opening between the atria of the heart that can cause strokes among other complications. The procedure employs a self-expanding, double-disc occluder composed of nitinol wire mesh, successfully blocking the PFO and halting the movement of clots between the atria.
Pre-order Your Report for Quick and Easy Delivery!
https://www.thebusinessresearchcompany.com/report/heart-defect-closure-device-global-market-report
Which Segments of the Heart Defect Closure Device Market Hold the Most Potential for Future Development?
The heart defect closure device market covered in this report is segmented –
1) By Type: Atrial Septal Defect (ASD) Closure Device, Left Atrial Appendage (LAA) Closure Devices, Patent Foramen Ovale (PFO) Closure Devices, Patent Ductus Arteriosus (PDA) Closure Devices, Ventricular Septal Defect (VSD) Closure Devices
2) By Material: Nitinol-Based Devices, Stainless Steel Devices, Other Materials
3) By Mode Of Delivery: Transcatheter Delivery, Surgical Delivery, Other Modes
4) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Atrial Septal Defect (ASD) Closure Device: Occluder Devices (Septal Occluders), Implantable Patch Devices, Self-Expanding Devices, Balloon-Expandable Devices
2) By Left Atrial Appendage (LAA) Closure Devices: Occluder Devices (WATCHMAN Device), Clip-Based Devices, Self-Expanding LAA Closure Devices
3) By Patent Foramen Ovale (PFO) Closure Devices: Septal Occluders, Self-Expanding Occluders, Balloon-Expandable Occluders
4) By Patent Ductus Arteriosus (PDA) Closure Devices: Coil-Based Closure Devices, Stent-Based Closure Devices, Amplatzer Occluders
5) By Ventricular Septal Defect (VSD) Closure Devices: Septal Occluder Devices, Balloon-Expandable Occluders, Self-Expanding Occluders
Which Geographic Locations Are Critical to the Growth of the Heart Defect Closure Device Market?
North America was the largest region in the heart defect closure device market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the heart defect closure device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Defining Aspects of the Heart Defect Closure Device Market Landscape?
A heart defect closure device is a medical device used to close abnormal openings or defects in the heart’s structure, typically in the septum, which is the wall separating the heart’s chambers. It is used to treat certain heart defects, such as atrial septal defects or patent foramen ovale, by closing heart’s wall. They are delivered via minimally invasive procedures, providing an effective and less invasive alternative to open-heart surgery for patients with these conditions.
Browse Through More Similar Reports By The Business Research Company:
Prosthetic Heart Valve Devices And Equipment Global Market Report 2024
Hearth Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/hearth-global-market-report
Heart Pump Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/heart-pump-devices-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
